UMass Chan Collaborates with Red Cell Partners to Evaluate AI Healthcare Innovations

The Health AI Assurance Laboratory at UMass Chan Medical School has formed a two-year collaboration with Red Cell Partners, an incubator and investment firm, to evaluate and certify AI tools for healthcare. This partnership allows UMass Chan to assess select healthcare AI products from Red Cell’s portfolio within the Partners Advancing Critical Technologies program, focusing on safety, effectiveness, and readiness for real-world applications. Dr. Adrian Zai, co-leader of the Assurance Lab, emphasized the initiative’s goal of establishing AI assurance guidelines to enhance patient care and make AI startups more competitive. Red Cell will provide healthcare AI products for rapid real-world evaluations, while UMass Chan will leverage its data access for research. The collaboration aims to expand the pipeline of AI innovators and capitalize on UMass Chan’s expertise in implementing AI in healthcare, aligning with their mission to serve underserved populations effectively.

Source link